Microcrystalline cellulose

Download report

Favorite

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

No data

Clinical

Clinical Trials

5526 clinical trials

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Type 2 diabetes mellitus	D003924	EFO_0001360	E11	43	43	130	88	56	356
Myelodysplastic syndromes	D009190	—	D46	74	134	15	1	16	209
Leukemia	D007938	—	C95	66	127	18	1	14	193
Healthy volunteers/patients	—	—	—	116	15	6	9	51	187
Myeloid leukemia acute	D015470	—	C92.0	76	98	17	1	7	171
Precursor cell lymphoblastic leukemia-lymphoma	D054198	—	C91.0	53	85	22	1	9	151
Lymphoma	D008223	—	C85.9	41	94	7	1	22	151
Non-hodgkin lymphoma	D008228	—	C85.9	44	81	3	1	8	111
B-cell chronic lymphocytic leukemia	D015451	—	C91.1	35	65	9	1	8	102
Multiple sclerosis	D009103	EFO_0003885	G35	7	21	19	14	25	82

Show 380 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Multiple myeloma	D009101	—	C90.0	27	51	4	—	9	82
Hodgkin disease	D006689	—	C81	22	53	7	—	7	76
Bcr-abl positive chronic myelogenous leukemia	D015464	EFO_0000340	—	15	49	3	—	4	64
Mantle-cell lymphoma	D020522	—	C83.1	25	36	3	—	6	58
Follicular lymphoma	D008224	—	C82	21	35	3	—	7	54
Prostatic neoplasms	D011471	—	C61	15	31	11	—	4	52
Waldenstrom macroglobulinemia	D008258	HP_0005508	C88.0	14	27	2	—	7	43
Myelomonocytic leukemia chronic	D015477	—	C93.1	18	25	2	—	4	41
Melanoma	D008545	—	—	20	23	1	—	—	40
Graft vs host disease	D006086	—	D89.81	5	28	9	—	2	39

Show 295 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Plasma cell neoplasms	D054219	—	—	15	31	—	—	8	50
Large-cell lymphoma anaplastic	D017728	—	C84.6	13	24	—	—	6	35
B-cell lymphoma marginal zone	D018442	—	C88.4	10	18	—	—	7	31
T-cell lymphoma peripheral	D016411	—	—	11	18	—	—	5	28
Lymphomatoid granulomatosis	D008230	—	C83.8	8	17	—	—	6	27
Extranodal nk-t-cell lymphoma	D054391	—	C86.0	7	15	—	—	6	25
Adult t-cell leukemia-lymphoma	D015459	—	C91.5	5	13	—	—	5	21
Hairy cell leukemia	D007943	—	C91.4	7	9	—	—	5	18
Myeloid leukemia accelerated phase	D015465	—	—	3	13	—	—	3	18
Kidney neoplasms	D007680	EFO_0003865	C64	3	13	—	—	3	17

Show 302 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Dengue	D003715	—	A90	6	—	—	—	—	6
Hepatic insufficiency	D048550	—	—	5	—	—	—	—	5
Healthy aging	D000073656	—	—	2	—	—	—	3	5
Pruritus	D011537	HP_0000989	L29	2	—	—	—	2	4
Fear	D005239	—	—	1	—	—	—	3	4
Primitive neuroectodermal tumors	D018242	—	—	1	—	—	—	2	3
Probiotics	D019936	—	—	1	—	—	—	2	3
Lipid metabolism disorders	D052439	—	—	1	—	—	—	2	3
Autism spectrum disorder	D000067877	HP_0000729	F84.0	2	—	—	—	1	3
Goiter	D006042	HP_0000853	E04.9	1	—	—	—	2	3

Show 79 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Affect	D000339	—	—	—	—	—	—	6	6
Sinus floor augmentation	D059546	—	—	—	—	—	—	5	5
Malnutrition	D044342	EFO_0008572	E40-E46	—	—	—	—	4	4
Peri-implantitis	D057873	EFO_1001390	—	—	—	—	—	4	4
Graves disease	D006111	EFO_0004237	E05.0	—	—	—	—	3	3
Pediatric obesity	D063766	—	—	—	—	—	—	3	3
Aortic valve stenosis	D001024	HP_0001650	—	—	—	—	—	3	3
Diet therapy	D004035	—	—	—	—	—	—	3	3
Placebos	D010919	—	—	—	—	—	—	3	3
Pre-eclampsia	D011225	EFO_0000668	O14	—	—	—	—	3	3